Termeh Feinberg, PhD, MPH
LecturerCards
About
Research
Publications
2026
Ginkgo biloba for cognitive impairment and dementia
Wieland L, Ludeman E, Chi Y, Feinberg T, Chen I, Chen K, Zhu Y, Wolverson E, Amri H. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Of Systematic Reviews 2026, 2026: cd013661. PMID: 41641880, PMCID: PMC12875036, DOI: 10.1002/14651858.cd013661.pub2.Peer-Reviewed Original ResearchConceptsMild cognitive impairmentRisk of adverse eventsRisk of biasSubjective cognitive complaintsCognitive complaintsStandardized mean differenceRandomized Controlled TrialsRisk of serious adverse eventsCognitive impairmentMean differenceClinical Dementia Rating ScaleInstrumental ADL scaleRisk ratioConfidence intervalsDiagnosis of mild cognitive impairmentLikert scaleCognitive problemsDementia Rating ScaleAlzheimer's Disease Assessment ScaleLow risk of biasPerceived Deficits QuestionnaireGlobal cognitive functionSix-point Likert scaleLow riskDisease Assessment ScaleIncidence rates of twelve chronic diseases/conditions in US adults: findings from a population-based study
Nahin R, Feinberg T, Grol-Prokopczyk H, Kapos F, Murray K, Scott R, Zajacova A. Incidence rates of twelve chronic diseases/conditions in US adults: findings from a population-based study. The Lancet Regional Health - Americas 2026, 54: 101342. PMID: 41561640, PMCID: PMC12813608, DOI: 10.1016/j.lana.2025.101342.Peer-Reviewed Original ResearchCoronary heart diseaseChronic obstructive pulmonary diseaseChronic diseases/conditionsIncidence rateOne-year incidence rateUS adultsAge-standardized incidence rateUS National InstitutesAssociated with baseline ageChronic painHigher rates of anxietyNon-Hispanic whitesHigh cholesterolPopulation-based studyHigher RatesRates of anxietyRates of hypertensionUS National Institutes of HealthPrivate health insuranceNational Institutes of HealthInstitutes of HealthObstructive pulmonary diseasePrevention initiativesSmoking statusBaseline ageHigh-impact chronic pain incidence among US adults: a brief report focused on socioeconomic factors
Kapos F, Feinberg T, Terman G, Nahin R. High-impact chronic pain incidence among US adults: a brief report focused on socioeconomic factors. AJPM Focus 2026, 100475. DOI: 10.1016/j.focus.2026.100475.Peer-Reviewed Original ResearchHigh-impact chronic painSocioeconomic positionChronic painUS adultsIndicators of socioeconomic positionAssociation of SEPIndicators of SEPSurvey-weighted analysisBaseline indicatorsPopulation healthPain preventionMedical careWork statusSocioeconomic factorsBaseline painCohort studyPain incidenceFamily incomeLiving arrangementsFood insecurityEducational attainmentPrimary outcomeEpidemiological studiesChronic pain incidencePain
2025
Update on the utilization of complementary therapies by adolescents with asthma in an urban population
Soffer G, Feinberg T, Kroll H, Reznik M. Update on the utilization of complementary therapies by adolescents with asthma in an urban population. Journal Of Asthma 2025, 62: 1304-1312. PMID: 40040497, DOI: 10.1080/02770903.2025.2475451.Peer-Reviewed Original ResearchAsthma Control TestCAM useUtilization of complementary therapiesPrevalence of CAM usePrescription adherenceEfficacy of CAMHealth-promoting behaviorsPrimary care clinicsElectronic health recordsCAM utilizationCare clinicsActivity prescriptionHealth recordsAlternative medicineComplementary therapyAsthma managementLack of associationOutpatient specialtyAsthma controlSelf-ReportAsthma severityLogistic regressionMind-BodyUrban adolescentsDemographic informationNatural Product Use for Chronic Pain: A New Survey of Patterns of Use, Beliefs, Concerns, and Disclosure to Providers
Seal K, Feinberg T, Moore L, Woodruff N, Purcell N, Bertenthal D, McCamish N, Becker W. Natural Product Use for Chronic Pain: A New Survey of Patterns of Use, Beliefs, Concerns, and Disclosure to Providers. Global Advances In Integrative Medicine And Health 2025, 14: 27536130251320101. PMID: 40026674, PMCID: PMC11869316, DOI: 10.1177/27536130251320101.Peer-Reviewed Original ResearchVeterans Health AdministrationChronic painPrimary carePain medicationPragmatic trialVA primary careVeteran focus groupsRespondents' mean ageNon-opioid pain medicationsPain management approachesNatural product useHealth AdministrationFocus groupsNP useParent trialPrescribed medicationsHispanic/Latinx ethnicityPrescribed opioidsDisabling painMedication substitutionProvidersVeteransMean ageClinical dataPain
2024
Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV
Miller E, McGinnis K, Edelman E, Feinberg T, Gordon K, Kerns R, Marshall B, Patterson J, McRae M. Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV. AIDS And Behavior 2024, 28: 3994-4004. PMID: 39264485, PMCID: PMC11586311, DOI: 10.1007/s10461-024-04494-w.Peer-Reviewed Original ResearchMental health classesSubstance use disordersOpioid use disorderHIV statusBuprenorphine initiationVeterans Aging Cohort StudyInitiate buprenorphineMental health diagnosesAging Cohort StudyBuprenorphine treatmentMultiple pain conditionsAssociated with HIV statusInfluence treatment retentionUse disorderTreatment of opioid use disorderHigher comorbidity burdenAge of patientsClinical encountersMental healthHealth diagnosisBlack veteransHealth classesLatent class analysisCohort studyPrescription dataConcordance of provider chart notation and guideline-based classification of asthma severity
Kroll H, Feinberg T, Soffer G, Reznik M. Concordance of provider chart notation and guideline-based classification of asthma severity. Journal Of Asthma 2024, 61: 1402-1411. PMID: 38717912, DOI: 10.1080/02770903.2024.2353106.Peer-Reviewed Original ResearchAsthma severity classificationChart notationUrban primary careClassification of asthma severityFair-to-goodWeighted kappa coefficientGuideline-based criteriaPrimary careNAEPP guidelinesDiagnosed asthmaConvenience sampleGuideline-basedAsthma criteriaPositive predictive valueAsthma severityAssess concordanceGuideline classificationPhysiciansEvaluate concordanceSeverity classificationClinic patientsPrescribed treatmentNAEPPMcNemar testKappa coefficientNatural Product Use Among Veterans with Chronic Pain: A Qualitative Study of Attitudes and Communication with Healthcare Providers
Moore L, Woodruff N, Seal K, Feinberg T, Purcell N. Natural Product Use Among Veterans with Chronic Pain: A Qualitative Study of Attitudes and Communication with Healthcare Providers. Journal Of General Internal Medicine 2024, 39: 2206-2214. PMID: 38689119, PMCID: PMC11347536, DOI: 10.1007/s11606-024-08746-2.Peer-Reviewed Original ResearchNatural product useChronic painHealthcare providersVeterans' beliefsPain managementPragmatic Randomized Controlled TrialSemi-structured interview guideRates of chronic painChronic pain managementQualitative study of attitudesRandomized Controlled TrialsApproachQualitative interviewsInterview guideVeterans' experiencesHealthcare systemAudio-recordedQualitative studyProvidersVeteransSub-studyProduct useHealthcareQualitative dataHealth concernValue providers
Academic Achievements & Community Involvement
Get In Touch
Contacts
Mailing Address
Yale School of Medicine
300 George St., 5th floor
New Haven, CT 06511
United States